Funder: American Cancer Society
Due Dates: June 1, 2026 (July review) | December 1, 2026 (December review)
Funding Amounts: Up to $75,000 total costs for a 1-year project; no indirect costs allowed.
Summary: Supports ongoing cancer research projects to validate and de-risk technologies for commercialization, providing entrepreneurial education and collaborative resources.
Key Information: Projects must be ongoing and commercially driven; new research or shifts in project direction are not eligible.